InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

InMode's stock valuation has fluctuated over time, with high multiples in 2021 due to impressive growth. The company's growth has since slowed down as it has matured. However, current multiples seem ...

Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we'll explain below. However, now that it's down 76% from highs, ...

InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M ...